Feel very confident invested here.
No nonsense company. Real business in the making. Urgently needed products. First rate management with track records and skin in the game. Amazing advisory groups and partners - all at the top of their respective fields. As much effort going into ensuring a substantial market for the products as there is going into proving up the tech. The latter being highly encouraging.
This is a clear opportunity to ride another Aus biotech success story a la resmed, cochlear, nanasonics and CSL.
Plenty of cash for nearly 2 years with promise of substantial grants in thst period.
A definite keeper for me.
Ann: Appendix 4C - quarterly, page-3
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.97 |
Change
-0.055(2.72%) |
Mkt cap ! $167.8M | |||
| Open | High | Low | Value | Volume |
| $1.97 | $1.97 | $1.97 | $3.142K | 1.599K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 255 | $1.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.97 | 401 | 1 |
View Market Depth
| Last trade - 11.01am 31/07/2024 (20 minute delay) ? |
| EMV (ASX) Chart |